While not a cell surface antigen, a lack of TSPO expression, a drug target for diabetes and obesity [31], was observed to uniquely characterize undifferentiated NP88 and NP110 progenitors (Additional file 8: Figure S4 and Additional file 7: Table S4). The gene discussed is CD53; the disease is obesity due to melanocortin 4 receptor deficiency.